Leap Therapeutics (LPTX) Short Interest Ratio & Short Volume $2.91 +0.13 (+4.68%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Leap Therapeutics Short Interest DataLeap Therapeutics (LPTX) has a short interest of 1.42 million shares, representing 4.97% of the float (the number of shares available for trading by the public). This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 4.4, indicating that it would take 4.4 days of the average trading volume of 256,240 shares to cover all short positions.Current Short Interest1,420,000 sharesPrevious Short Interest1,420,000 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$4.23 millionShort Interest Ratio4.4 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares38,318,000 sharesFloat Size28,550,000 sharesShort Percent of Float4.97%Today's Trading Volume327,031 sharesAverage Trading Volume256,240 sharesToday's Volume Vs. Average128% Short Selling Leap Therapeutics? Sign up to receive the latest short interest report for Leap Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLPTX Short Interest Over TimeLPTX Days to Cover Over TimeLPTX Percentage of Float Shorted Over Time Ad Weiss RatingsBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $125,000 by the end of his first month in office.This could be his favorite coin. Leap Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/20241,420,000 shares $4.23 million No Change5.0%4.4 $2.98 11/15/20241,420,000 shares $3.89 million +40.6%5.0%5.3 $2.74 10/31/20241,010,000 shares $3.78 million +39.6%3.5%4.3 $3.74 10/15/2024723,500 shares $1.66 million -19.5%2.4%4.9 $2.29 9/30/2024899,100 shares $2.31 million -11.0%3.0%7.8 $2.57 9/15/20241,010,000 shares $2.77 million -2.9%3.4%8.4 $2.74 Get the Latest News and Ratings for LPTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Leap Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/31/20241,040,000 shares $3.02 million -15.5%3.5%8.9 $2.90 8/15/20241,230,000 shares $3.03 million +17.1%4.1%9.2 $2.46 7/31/20241,050,000 shares $2.25 million -7.1%3.5%7.2 $2.14 7/15/20241,130,000 shares $2.46 million +6.6%3.8%6.8 $2.18 6/30/20241,060,000 shares $2.08 million -14.5%3.6%3.6 $1.96 6/15/20241,240,000 shares $2.62 million -3.1%4.2%4.2 $2.11 5/31/20241,280,000 shares $3.11 million -5.2%5.0%4.3 $2.43 5/15/20241,350,000 shares $3.78 million -0.7%5.3%4.4 $2.80 4/30/20241,360,000 shares $4.22 million -6.2%5.6%4.5 $3.10 4/15/20241,450,000 shares $4.35 million +27.2%6.2%4.5 $3.00 3/31/20241,140,000 shares $3.03 million +0.9%4.9%4.7 $2.66 3/15/20241,130,000 shares $2.50 million -3.4%4.8%4.4 $2.21 2/29/20241,170,000 shares $3.26 million +4.5%5.0%4.4 $2.79 2/15/20241,120,000 shares $3.66 million +74.8%4.8%4 $3.27 1/31/2024640,800 shares $1.92 million +7.3%2.7%2.2 $3.00 1/15/2024597,400 shares $2.10 million +5.3%2.5%2.3 $3.51 12/31/2023567,300 shares $2.35 million +2.9%2.4%2.4 $4.15 12/15/2023551,200 shares $1.67 million -2.2%2.4%1.8 $3.03 11/30/2023563,600 shares $1.27 million -29.4%2.4%2 $2.25 11/15/2023798,100 shares $1.28 million +7.2%3.4%2.9 $1.60 10/31/2023744,200 shares $1.09 million +24.6%3.2%3.1 $1.47 10/15/2023597,500 shares $908,200.00 -15.1%2.5%2 $1.52 9/30/2023703,400 shares $970,692.00 +2.7%3.0%2.1 $1.38 9/15/2023684,800 shares $1.08 million +1.9%2.9%2.7 $1.57 8/31/2023671,800 shares $1.50 million -3.2%3.2%2.6 $2.23 8/15/2023694,300 shares $1.76 million -5.3%3.3%2.7 $2.54 7/31/2023732,800 shares $2.01 million -36.3%7.5%2.9 $2.74 7/15/20231,150,000 shares $3.62 million +3.6%12.0%6.4 $3.15 6/30/20231,110,000 shares $3.47 million +6.7%11.6%7.9 $3.13 6/15/20231,040,000 shares $6.29 million -89.8%10.8%8.6 $6.05 5/31/202310,230,000 shares $9.10 million -11.2%N/A10.5 $0.89 5/15/202311,520,000 shares $5.18 million +0.1%N/A14.7 $0.45 4/30/202311,510,000 shares $4.50 million No ChangeN/A19.4 $0.39 4/15/202311,510,000 shares $4.52 million +1.1%N/A16.3 $0.39Cackling Kamala hates this company (Ad)Do you want to see one of the most exciting election trades of all time? A trade that could help America become 100% energy independent… Reduce energy costs to virtually zero… And hand investors what could be a stunning return in just a few years’ time? It all has to do with a little known company that is helping to kick off the next great American energy revolution. Before that happens, you need to see the details here. 3/31/202311,390,000 shares $3.87 million +20.0%N/A15.8 $0.34 3/15/20239,490,000 shares $3.92 million +5.8%N/A12.2 $0.41 2/28/20238,970,000 shares $5.11 million +45.2%N/A12.3 $0.57 2/15/20236,180,000 shares $3.72 million +22.1%N/A8.5 $0.60 1/31/20235,060,000 shares $3.36 million +15.0%N/A6.2 $0.67 1/15/20234,400,000 shares $2.56 million +57.1%N/A5.5 $0.58 12/30/20222,800,000 shares $1.26 million +27.3%N/A4.6 $0.45 12/15/20222,200,000 shares $1.10 million -1.4%N/A3.9 $0.50 11/30/20222,230,000 shares $1.35 million -6.3%N/A3.6 $0.60 11/15/20222,380,000 shares $1.67 million -32.6%N/A3.5 $0.70 10/31/20223,530,000 shares $3.00 million +10.3%N/A5.1 $0.85 10/15/20223,200,000 shares $2.82 million +10.7%N/A5.3 $0.88 9/30/20222,890,000 shares $2.54 million +10.7%N/A4.7 $0.88 9/15/20222,610,000 shares $3.08 million No ChangeN/A3.9 $1.18 8/31/20222,610,000 shares $3.71 million +6.5%N/A4.1 $1.42 8/15/20222,450,000 shares $3.50 million -70.6%N/A3.9 $1.43 7/31/20228,340,000 shares $8.67 million -37.4%N/A12.1 $1.04 7/15/202213,320,000 shares $14.52 million -1.4%N/A18.1 $1.09 6/30/202213,510,000 shares $15.54 million -1.0%N/A17 $1.15 6/15/202213,650,000 shares $13.92 million -1.1%N/A17.2 $1.02 5/31/202213,800,000 shares $14.90 million -1.9%N/A17.8 $1.08 5/15/202214,070,000 shares $18.43 million No ChangeN/A18.7 $1.31 4/30/202214,070,000 shares $18.15 million +1.2%N/A17.3 $1.29 4/15/202213,910,000 shares $22.12 million -0.1%N/A13.6 $1.59 3/31/202213,930,000 shares $24.38 million +0.4%N/A10.7 $1.75 3/15/202213,880,000 shares $23.32 million No ChangeN/A8.8 $1.68 2/28/202213,880,000 shares $27.62 million -2.3%N/A8 $1.99 2/15/202214,200,000 shares $34.08 million +4.1%N/A7.4 $2.40 1/31/202213,640,000 shares $26.46 million -8.1%N/A7 $1.94 1/15/202214,840,000 shares $42.15 million +12.9%N/A7.7 $2.84 12/31/202113,150,000 shares $42.61 million +12.9%N/A6.7 $3.24 12/15/202111,650,000 shares $29.13 million +12.8%N/A4.3 $2.50 11/30/202110,330,000 shares $26.96 million +3.8%N/A1.6 $2.61 11/15/20219,950,000 shares $23.88 million -5.8%N/A1.6 $2.40 10/29/202110,560,000 shares $29.46 million -1.5%N/A1.7 $2.79 10/15/202110,720,000 shares $33.77 million -6.1%N/A1.8 $3.15 9/30/202111,410,000 shares $45.75 million +152.4%N/A2.1 $4.01 9/15/20214,520,000 shares $8.72 million +99.1%9.8%1 $1.93 8/31/20212,270,000 shares $3.90 million +33.5%4.9%4 $1.72 8/13/20211,700,000 shares $2.86 million +39.3%3.7%4.3 $1.68 7/30/20211,220,000 shares $1.73 million -0.8%2.7%3.4 $1.42 7/15/20211,230,000 shares $1.72 million -2.4%2.7%4.1 $1.40 6/30/20211,260,000 shares $2.07 million +2.4%2.8%3.6 $1.64 6/15/20211,230,000 shares $2.19 million +8.9%2.7%3.1 $1.78 5/28/20211,130,000 shares $1.83 million -4.2%2.5%2 $1.62 5/14/20211,180,000 shares $1.75 million -21.9%N/A2 $1.48 4/30/20211,510,000 shares $2.57 million +2.7%N/A2 $1.70 4/15/20211,470,000 shares $2.56 million -7.6%N/A1.7 $1.74 3/31/20211,590,000 shares $2.93 million +12.0%N/A1.8 $1.84 3/15/20211,420,000 shares $3.39 million +16.4%N/A1.3 $2.39Cackling Kamala hates this company (Ad)Do you want to see one of the most exciting election trades of all time? A trade that could help America become 100% energy independent… Reduce energy costs to virtually zero… And hand investors what could be a stunning return in just a few years’ time? It all has to do with a little known company that is helping to kick off the next great American energy revolution. Before that happens, you need to see the details here. 2/26/20211,220,000 shares $3.00 million +15.1%N/A1.2 $2.46 2/12/20211,060,000 shares $2.92 million +13.7%N/A1.1 $2.75 1/29/2021932,600 shares $2.15 million -23.6%N/A0.9 $2.31 1/15/20211,220,000 shares $2.71 million +13.0%N/A1.3 $2.22 12/31/20201,080,000 shares $2.39 million +38.8%N/A1.2 $2.21 12/15/2020778,400 shares $1.43 million +24.3%N/A0.9 $1.84 11/30/2020626,300 shares $995,817.00 +8.2%N/A1 $1.59 11/15/2020579,000 shares $926,400.00 +3.0%N/A1 $1.60 10/30/2020562,200 shares $1.11 million +4.6%N/A1.1 $1.98 10/15/2020537,700 shares $1.15 million -34.6%N/A1.1 $2.13 9/30/2020821,800 shares $1.63 million -5.3%N/A1.2 $1.98 9/15/2020868,100 shares $1.66 million +6.3%N/A1.1 $1.91 8/31/2020816,400 shares $1.42 million -10.2%N/A0.9 $1.74 8/14/2020908,900 shares $1.73 million -13.4%N/A1 $1.90 7/31/20201,050,000 shares $2.15 million -16.0%N/A1.2 $2.05 7/15/20201,250,000 shares $2.26 million +5.0%N/A1.6 $1.81 6/30/20201,190,000 shares $2.59 million -16.8%N/A2.2 $2.18 6/15/20201,430,000 shares $3.62 million +5.2%N/A3.3 $2.53 5/29/20201,360,000 shares $3.22 million -2.9%6.4%4.7 $2.37 5/15/20201,400,000 shares $3.21 million -2.1%6.6%4.3 $2.29 4/30/20201,430,000 shares $3.13 million +32.4%6.7%3.3 $2.19 4/15/20201,080,000 shares $1.92 million -4.4%5.1%2 $1.78 3/31/20201,130,000 shares $2.71 million -35.2%5.3%1.9 $2.40 3/13/20201,742,400 shares $2.94 million -5.3%12.0%3.2 $1.69 2/28/20201,840,000 shares $2.41 million +21.9%12.7%2.2 $1.31 2/14/20201,510,000 shares $3.35 million -7.9%10.4%1.9 $2.22 1/31/20201,640,000 shares $4.41 million +41.4%11.3%2.4 $2.69 1/15/20201,160,000 shares $2.47 million +23.1%8.0%1.8 $2.13 12/31/2019942,100 shares $1.79 million +1.9%6.5%1.8 $1.90 LPTX Short Interest - Frequently Asked Questions What is Leap Therapeutics' current short interest? Short interest is the volume of Leap Therapeutics shares that have been sold short but have not yet been closed out or covered. As of November 30th, investors have sold 1,420,000 shares of LPTX short. 4.97% of Leap Therapeutics' shares are currently sold short. Learn More on Leap Therapeutics' current short interest. What is a good short interest ratio for Leap Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LPTX shares currently have a short interest ratio of 4.0. Learn More on Leap Therapeutics's short interest ratio. What is a good short interest percentage for Leap Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.97% of Leap Therapeutics' floating shares are currently sold short. What is Leap Therapeutics' float size? Leap Therapeutics currently has issued a total of 38,318,000 shares. Some of Leap Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Leap Therapeutics currently has a public float of 28,550,000 shares. How does Leap Therapeutics' short interest compare to its competitors? 4.97% of Leap Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Leap Therapeutics: ChromaDex Co. (4.15%), Zevra Therapeutics, Inc. (8.12%), Arcturus Therapeutics Holdings Inc. (17.78%), Corvus Pharmaceuticals, Inc. (5.46%), SIGA Technologies, Inc. (9.13%), Kodiak Sciences Inc. (2.73%), Verve Therapeutics, Inc. (28.32%), GH Research PLC (6.50%), Y-mAbs Therapeutics, Inc. (10.33%), Korro Bio, Inc. (5.39%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Leap Therapeutics stock? Short selling LPTX is an investing strategy that aims to generate trading profit from Leap Therapeutics as its price is falling. LPTX shares are trading up $0.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Leap Therapeutics? A short squeeze for Leap Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LPTX, which in turn drives the price of the stock up even further. How often is Leap Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LPTX, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies ChromaDex Short Interest Zevra Therapeutics Short Interest Arcturus Therapeutics Short Interest Corvus Pharmaceuticals Short Interest SIGA Technologies Short Interest Kodiak Sciences Short Interest Verve Therapeutics Short Interest GH Research Short Interest Y-mAbs Therapeutics Short Interest Korro Bio Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LPTX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Leap Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Leap Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
